Article Details
Retrieved on: 2021-04-28 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Developed by Alexion Pharmaceuticals, Ultomiris is an antibody-based therapy that works by blocking the activity of the C5 complement protein, ...
Article found on: ahusnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here